ALCMI Consortium
The ALCMI Consortium is a dedicated network of lung cancer clinical research physicians from many of the most recognized and prestigious oncology medical institutions in the world. ALCMI’s Master Collaboration Agreement creates an opportunity for rapid clinical trial launch – whether center-based or through remote decentralized clinical trial (DCT) methods – and supported by ALCMI’s robust operational platforms and highly-skilled clinical research workforce. All ALCMI Consortium trials adhere to the International Conference of Harmonization (ICH) standards, Good Clinical Practice (GCP) best practices, and U.S. Food and Drug Administration (FDA) regulations.
Baptist Memorial
Memphis, TN
Boca Raton Regional
Boca Raton, FL
City of Hope
Los Angeles, CA
Dana Farber Cancer Institute
Boston, MA
Dignity Health
Sacramento, CA
El Camino Hospital
San Francisco, CA
Institute Gustave Roussy
Paris, France
Harvard Medical School
Boston, MA
Hoag Hospital
Newport Beach, CA
Massachusetts General Hospital
Boston, MA
Memorial Care
Los Angeles, CA
Montefiore Medical Center
Bronx, NY
Northside Hospital
Atlanta, GA
New York University
New York, NY
Ohio State University
Columbus, OH
Palo Alto Medical Foundation
Palo Alto, CA
Rush University Medical Center
Chicago, IL
St. Louis Cancer Care
St. Louis, MO
University of California – Davis
San Francisco, CA
University of California – San Diego
San Diego, CA
University of California – San Francisco
San Francisco, CA
University of Manchester
Oxford, England
University of Torino
Turin, Italy
University of Southern California
Los Angeles, CA
Vanderbilt University Medical Center
Nashville, TN
Washington University – St. Louis
St. Louis, MO